Attenuation of Thyroid Hormone Action by 1,25 Dihydroxyvitamin D3in Pituitary Cells*
- 1 February 1989
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 124 (2) , 930-936
- https://doi.org/10.1210/endo-124-2-930
Abstract
Interactions between thyroid hormone and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] were examined in a rat pituitary tumor cell line, GH4C1. Cells were incubated in thyroid hormone-depleted medium for 2 days, and specific nuclear binding of [125I]T3 was measured. 1,25-(OH)2D3 decreased nuclear [125I]T3 binding without changing total cellular uptake of [125I]T3. This 1,25-(OH)2D3 effect required 2-3 h to become evident and 24 h to reach a maximum (40-50% of control) and was reversible. Treatment with 1,25-(OH)2D3 for 8 h changed the maximal binding capacity for [125I]T3 from 80.2 .+-. 2.9 to 50.3 .+-. 6.3 fmol/106 cells, whereas Kd was not significantly altered. The decrease in [125I]T3 binding was dose dependent, with an IC50 for 1,25-(OH)2D3 of 1 nM in thyroid hormone-depleted medium. 1,25-(OH)2D3 caused little change in [125I]T3 binding to isolated nuclei, i.e. 1,25-(OH)2D3 does not compete directly with [125I]T3 for binding. It is unlikely that 1,25-(OH)2D3 decreased [125I]T3 binding by increasing the concentration of intracellular free calcium ([Ca2+]i), since 1,25-(OH)2D3 did not change [Ca2+]i in Indo-I-loaded GH4C1 cells. Two major species (6 and 2.6 kilobases) of mRNA for c-erb-A, which have been reported to encode nuclear thyroid hormone receptors, were found by Northern blot analysis, and both were decreased by treatment with 1,25-(OH)2D3 for 8 h. T3 (2 nM) caused a 3-fold increase in GH production over 72 h and 1,25-(OH)2D3 inhibited GH induction by T3, with an IC50 at approximately 1 nM, 1,25-(OH)2D3 stimulated PRL synthesis 5-fold when 10 nM T3 was present, but not when T3 was absent. In summary, 1,25-(OH)2D3 caused a dose-dependent down-regulation of nuclear thyroid hormone receptors at a pretranslational level and diminished GH induction by T3. These results suggest that 1,25-(OH)2D3 inhibits GH synthesis indirectly, at least partly, by attenuating endogenous thyroid hormone action.This publication has 23 references indexed in Scilit:
- Relationship between thyroid and glucocorticoid hormone receptor occupancy, growth hormone gene transcription, and mRNA accumulation.Journal of Biological Chemistry, 1984
- Hormonal regulation of the growth hormone gene. Relationship of the rate of transcription to the level of nuclear thyroid hormone-receptor complexes.Journal of Biological Chemistry, 1984
- VITAMIN D STIMULATES PROLACTIN SYNTHESIS BY CH4C1CELLS INCUBATED IN CHEMICALLY DEFINED MEDIUMEndocrinology, 1982
- Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cellsMolecular and Cellular Endocrinology, 1982
- Receptor for 1,25-Dihydroxyvitamin D3 in GH3 pituitary cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Regulation of pituitary function and prolactin production in the GH4 cell line by vitamin D.Journal of Biological Chemistry, 1981
- Thyrotropes in the pituitary are target cells for 1,25 dihydroxy vitamin D3Cell and tissue research, 1980
- Depletion of L-3,5,3'-Triiodothyronine and L-Thyroxine in Euthyroid Calf Serum for Use in Cell Culture Studies of the Action of Thyroid Hormone*Endocrinology, 1979
- Establishment of Clonal Strains of Rat Pituitary Tumor Cells That Secrete Growth Hormone1,2Endocrinology, 1968
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951